Listed by the USPTO as CHEN, CATHERYNE
Tech Center 1600 • Art Units: 1655
This examiner grants 38% of resolved cases
CHEN, CATHERYNE is a USPTO patent examiner in tech center 1600 and art unit 1655. The profile records 793 resolved cases, an allowance rate of 37.5%, and a median of 1551 days to allowance. The interview lift is 17.9%, showing a positive association with interviews despite the lower overall allowance result recorded here.
The listed companies are TCI Co., Ltd., Nicoventures Trading Limited, and Nutrition21, LLC. The listed firms are GREER, BURNS & CRAIN, LTD, SUGHRUE MION, PLLC, and Wideband IP Office. Practitioners may wish to plan for extended prosecution timing and give interview preparation a defined role in response strategy.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18579985 | CONSTITUENT, DERIVATIVE OR EXTRACT OF CANNABIS IN A WATER SOLUBLE MATRIX | Non-Final OA | Nicoventures Trading Limited |
| 18291577 | COMPOSITION, AND EXTRACT OF CHLAMYDOMONAS REINHARDTII | Final Rejection | HONDA MOTOR CO., LTD. |
| 18822591 | Application of Gastrodia elata Blume derived nano-extracellular vesicles in the preparation of drugs for the prevention and/or treatment of subarachnoid hemorrhage | Non-Final OA | Zhejiang University |
| 18615328 | STIMULATION OF ANGIOGENESIS BY FIBROBLAST DERIVED EXOSOMES | Non-Final OA | FIGENE, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy37.5% of resolved applications examined by Catheryne Chen were allowed (793 resolved cases), compared with 43.3% across Art Unit 1655 over the last five years.
This examiner's interview lift is +17.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Catheryne Chen took 1,551 days on average from filing to allowance.
Catheryne Chen examines applications in Art Unit 1655 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
